High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: Results of a phase II study of the eastern cooperative oncology group

Cancer

Volumn 83, Issue 9, 1998, Pages 1908-1916

  Keller, Steven M ^a   Ryan, Louise M ^b   Coia, Lawrence R ^c   Dang, Phuong ^b   Vaught, David J ^d   Diggs, Charles ^e   Weiner, Louis M ^f   Benson, Al B ^g  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Rutgers Health Community Medical Center   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e DEAN MEDICAL CENTER   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Esophageal neoplasm; Medical ontology; Radiotherapy; Surgery

Indexed keywords

FLUOROURACIL; MITOMYCIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; DRUG RESPONSE; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LOWER ESOPHAGUS SPHINCTER; LUNG TOXICITY; MALE; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0032211321     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981101)83:9<1908::AID-CNCR5>3.0.CO;2-6     Document Type: Article

References (34)

1. Buroker TR, Nigro N, Bradley G, Pelok L, Chomchai C, Considine B, et al. Combined therapy for cancer of the anal canal: A follow-up report. Dis Colon Rectum 1977;20:677-8.
2. Newman HK, Quan SH. Multi-modality therapy for epidermoid carcinoma of the anus. Cancer 1976;37:12-9.
3. Sischy B, Remington JH, Sobel SH, Savlov ED. Treatment of carcinoma of the rectum and squamous carcinoma of the anus by combination chemotherapy, radiotherapy, and operation. Surg Gynecol Obstet 1980;151:369-71.
4. Franklin R, Steiger Z, Vaishampayan G, Asfaw I, Rosenberg J, Loh J, et al. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 1983;51:1062-71.
5. Steiger Z, Franklin R, Wilson RF, Leichman L, Seydel H, Loh JJ, et al. Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy and surgical therapy. J Thorac Cardiovasc Surg 1981;82:713-9.
6. Newaishy GA, Read GA, Duncan W, Kerr GR. Results of radical radiotherapy of squamous cell carcinoma of the esophagus. Clin Radiol 1982;33:347-52.
7. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-c, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
8. Sauter ER, Coia LR, Keller SM. Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction. Ann Surg Oncol 1994;1: 5-10.
9. Algan O, Coia LR, Keller SM, Engstrom PF, Hanks GE, Schultheiss TE. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy; results of sequential nonrandomized Phase II studies. Int J Radiat Oncol Biol Phys 1995;32:753-61.
10. Cox DR. Analysis of binary data. London: Chapman Hall, 1970.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
12. Mantel N, Byar DP. Evaluation of response-time data involving transient states: an illustration using heart-transplant data. J Am Stat Assoc 1974;69:81-6.
13. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in the rates of esophageal adenocarcinoma: an update [letter]. JAMA 1993;270:1320.
14. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
15. Ezdinli EZ, Gelber R, Desai DV, Falkson G, Moertel CG, Hahn RG. Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Group experience. Cancer 1980; 46:2149-53.
16. Comis RL, Carter SK. A review of chemotherapy in gastric cancer. Cancer 1974;34:1576-86.
17. Vietti J, Eggerding F, Valeriote F. Combined effect of x-irradiation and 5-FU on survival of transplanted leukemic cells. J Natl Cancer Inst 1971;47:865-70.
18. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X-rays. Int J Radiat Oncol Biol Phys 1982;8:1923-33.
19. Desai PB, Borges EJ, Vohra VG, Paymaster JC. Carcinoma of the esophagus in India. Cancer 1969;23:979-89.
20. Engstrom P, Lavin P, Klaasen D. Phase II evaluation of mitomycin and cisplatin in advanced esophageal cancer. Cancer Treat Rep 1983;67:713-5.
21. Moertel GG, Reitemier RJ, Hahn RG. Mitomycin-C therapy in advanced gastrointestinal cancer. JAMA 1968;204:1045-8.
22. Rockwell S, Kennedy KA. Combination therapy with radiation and mitomycin-c: preliminary results with EMT6 tumor cells in vitro and in vivo. Int J Radiat Oncol Biol Phys 1979; 5:1673-6.
23. Rockwell S. Cytotoxicities of mitomycin-C and x-rays to aerobic and hypoxic cells in vitro. Int J Radiat Biol Phys 1982;8:1035-9.
24. Adelstein DJ, Rice TW, Boyce GA, Sivak MV, Van Kirk MA, Kirby TJ, et al. Adenocarcinoma of the esophagus and gastroesophageal junction. Am J Clin Oncol (CCT) 1994;17: 14-8.
25. Ajani JA, Roth JA, Ryan MB, Putnam JB, Pazdur R, Levin B, et al. Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 1993;11: 22-8.
26. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993;11:1118-23.
27. Naunheim KS, Petruska PJ, Roy TS, Schlueter BA, Kim H, Baue AE. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 1995;59:1085-91.
28. Urba SG, Orringer MB, Perez-Tamayo C, Bromberg I, Forastiere A. Concurrent preoperative chemotherapy and radiation therapy in localized esophageal carcinoma. Cancer 1992;69:285-91.
29. Ajani JA, Roth JA, Ryan B, McMurtey M, Rich TA, Jackson DE, et al. Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastrointestinal junction. J Clin Oncol 1990;8:1231-8.
30. Whittington R, Coia LR, Haller DG, Rubenstein JH, Rosato EF. Adenocarcinoma of the esophagus and esophago-gastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment. Int J Radiat Oncol Biol Phys 1990;19:593-603.
31. Urba S, Orringer M, Turrisi A, Whyte R, Natale R, Iannetoni M, et al. A randomized trial comparing transhiatal esophagectomy to preoperative concurrent chemoradiotherapy followed by esophagectomy in locoregional esophageal carcinoma [abstract 475]. Proc Am Soc Clin Oncol 1995;14:199.
32. Urba S, Orringer M, Turrisi A, Whyte R, Iannettoni M, Forastiere A. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: updated analysis [abstract 983]. Proc Am Soc Clin Oncol 1997;16:277a.
33. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-7.
34. Donnelly RJ, Girling DJ. Preoperative chemotherapy for cancer of the oesophagus [letter]. Br J Surg 1992;79:843.